HIV vaccine study with treatment pause for Thai adults
Treatments studied
Part of Immune system & allergy, Infections clinical trials.
This study tests whether adding an experimental vaccine can help your immune system control HIV during a temporary break from your antiretroviral therapy (ART). If you have been on ART since shortly after infection with a suppressed viral load, this trial could help you understand if a 'functional cure' is possible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a Thai national aged 18 to 60 years.
- You have been on uninterrupted ART for at least 48 weeks and started ART during acute infection.
- Your HIV viral load has been under 50 copies/mL for at least the past 48 weeks.
- You have a CD4 count of 400 or higher, and are in overall good health.
- You must be willing to pause your ART for up to 50 weeks and restart it as directed.
- You must agree to use reliable contraception (if applicable) and follow safety rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving two powerful HIV-fighting antibodies (called broadly neutralizing monoclonal antibodies) along with starting standard HIV medications soon after infection can help control the virus without needing daily pills. If successful, it might allow people to take a 'treatment pause' while keeping their immune system healthy.
This study tests an experimental medication in healthy volunteers to see how it is processed by the body and whether it is safe. You may not receive direct benefit, but your participation helps find better treatments for people with HIV.
This study tests a new long-acting medicine that may help prevent HIV. It is given as an injection, and the study checks how safe it is and how it works in healthy volunteers.
This study tests a new injectable drug (VH4011499) for safety and how the body processes it. It's for healthy adults without HIV, and participants will get either the study drug or a placebo (an inactive shot).
This study looks at what happens when HIV treatment (ART) is intentionally paused in people who are already enrolled in a specific research study (RV254) and recently joined a protocol that included an earlier treatment pause. It may help researchers understand safety and how to manage treatment changes, but it has strict participation and consent requirements.
This trial tests a new malaria vaccine in healthy Thai adults. Participants will receive the vaccine and then be exposed to malaria in a controlled setting to see if the vaccine protects them. If you qualify, you'll be closely monitored and treated.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.